# Modified Pectoral Nerves Block Versus Serratus Plane Block in Major Breast Cancer Surgery

> **NCT02946294** · PHASE2 · COMPLETED · sponsor: **Cairo University** · enrollment: 90 (actual)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** Bupivacaine 0.25% with epinephrine
- **DRUG:** Bupivacaine 0.25% with epinephrine

## Key facts

- **NCT ID:** NCT02946294
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2017-12-04
- **Final completion:** 2017-12-11
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2017-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02946294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02946294, "Modified Pectoral Nerves Block Versus Serratus Plane Block in Major Breast Cancer Surgery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02946294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*